AstraZeneca/ Diabetes/ Diabetes/ News/ News/ R&D/ UK & Europe AstraZeneca improves diabetes pen to maintain its market share Piotr Wnuk AstraZeneca, Bydureon, Diabetes, GLP-1 0 Comment The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug Share X AstraZeneca improves diabetes pen to maintain its market share https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/
